04/23/2024 | Press release | Distributed by Public on 04/23/2024 11:03
FORM C |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL |
|
OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Filer CIK: |
0001857825
|
Filer CCC: |
XXXXXXXX
|
Period: |
12-31-2023
|
Is this a LIVE or TEST Filing? | LIVE TEST |
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | |
Would you like a Return Copy? |
Name: |
|
Phone Number: |
|
Contact E-Mail Address: |
|
Notify via Filing Website only? |
Name of Issuer: |
Covira Surgical, Inc.
|
Form: |
Corporation
|
Jurisdiction of Incorporation/Organization: |
DELAWARE
|
Date of Incorporation/Organization: |
09-07-2018
|
Address 1: |
3333 Green Bay Road Office L-404
|
City: |
North Chicago
|
State/Country: |
ILLINOIS
|
Mailing Zip/Postal Code: |
60064
|
Website of Issuer: |
https://www.covirasurgical.com/
|
Current Number of Employees: |
8
|
Total Assets Most Recent Fiscal Year-end: |
321647.00
|
Total Assets Prior Fiscal Year-end: |
683473.00
|
Cash and Cash Equivalents Most Recent Fiscal Year-end: |
95971.00
|
Cash and Cash Equivalents Prior Fiscal Year-end: |
581973.00
|
Accounts Receivable Most Recent Fiscal Year-end: |
0.00
|
Accounts Receivable Prior Fiscal Year-end: |
7000.00
|
Short-term Debt Most Recent Fiscal Year-end: |
0.00
|
Short-term Debt Prior Fiscal Year-end: |
0.00
|
Long-term Debt Most Recent Fiscal Year-end: |
199000.00
|
Long-term Debt Prior Fiscal Year-end: |
199000.00
|
Revenue/Sales Most Recent Fiscal Year-end: |
282875.00
|
Revenue/Sales Prior Fiscal Year-end: |
0.00
|
Cost of Goods Sold Most Recent Fiscal Year-end: |
0.00
|
Cost of Goods Sold Prior Fiscal Year-end: |
0.00
|
Taxes Paid Most Recent Fiscal Year-end: |
0.00
|
Taxes Paid Prior Fiscal Year-end: |
0.00
|
Net Income Most Recent Fiscal Year-end: |
-360719.00
|
Net Income Prior Fiscal Year-end: |
-367317.00
|
Issuer: |
Covira Surgical Inc
|
Signature: |
Peter Farmakis
|
Title: |
CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer
|
Signature: |
PETER FARMAKIS
|
Title: |
CEO
|
Date: |
04-23-2024
|